This page lists the SEC filings reported by Lion Point Capital, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Lion Point Capital, LP | DURECT CORP | - | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Lion Point Capital, LP | MARINUS PHARMACEUTICALS, INC. | 2,134,337 | 3.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Lion Point Capital, LP | MARINUS PHARMACEUTICALS, INC. | 4,779,648 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Lion Point Capital, LP | DURECT CORP | 1,428,306 | 6.3% | EDGAR |
| SC 13D/A | 2022-06-07 | Lion Point Capital, LP | SIERRA WIRELESS INC | 1,810,671 | 4.7% | EDGAR |
| SC 13G/A | 2022-02-14 | Lion Point Capital, LP | MARINUS PHARMACEUTICALS INC | 3,629,622 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-14 | Lion Point Capital, LP | DURECT CORP | 15,486,004 | 6.8% | EDGAR |
| SC 13G/A | 2022-02-14 | Lion Point Capital, LP | BATTALION OIL CORP | 352,851 | 2.2% | EDGAR |
| SC 13G/A | 2021-02-12 | Lion Point Capital, LP | DURECT CORP | 17,730,680 | 8.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Lion Point Capital, LP | MARINUS PHARMACEUTICALS INC | 4,568,934 | 12.2% | EDGAR |
| SC 13G/A | 2021-02-12 | Lion Point Capital, LP | LUMOS PHARMA, INC. | 407,192 | 4.9% | EDGAR |
| SC 13G | 2021-02-12 | Lion Point Capital, LP | BATTALION OIL CORP | 935,981 | 5.8% | EDGAR |
| SC 13G/A | 2021-01-11 | Lion Point Capital, LP | BurgerFi International, Inc. | 2,745,938 | 15.7% | EDGAR |
| SC 13D/A | 2020-11-27 | Lion Point Capital, LP | Canadian Solar Inc. | 2,453,724 | 4.1% | EDGAR |
| SC 13D/A | 2020-10-28 | Lion Point Capital, LP | Canadian Solar Inc. | 4,550,133 | 7.6% | EDGAR |
| SC 13G | 2020-08-13 | Lion Point Capital, LP | Opes Acquisition Corp. | 945,938 | 12.0% | EDGAR |
| SC 13D/A | 2020-04-20 | Lion Point Capital, LP | SIERRA WIRELESS INC | 2,144,396 | 5.9% | EDGAR |
| SC 13D | 2020-04-06 | Lion Point Capital, LP | SIERRA WIRELESS INC | 2,144,396 | 5.9% | EDGAR |
| SC 13G | 2020-02-14 | Lion Point Capital, LP | DURECT CORP | 18,750,000 | 9.7% | EDGAR |
| SC 13G | 2020-02-14 | Lion Point Capital, LP | MARINUS PHARMACEUTICALS INC | 6,374,740 | 7.7% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.